Damage to the nerve roots of the brachial plexus in the course of Lyme disease in a 15-year-old girl
, 1, 1, 1, 1, 2, 2
Abstract
Lyme disease is a multi-organ infectious disease and the most common vector-borne disease in Europe and North America.
An infection is caused by the spirochetes Borrelia burgdorferi, B. afzelii, and B. garinii, affecting all age groups, especially in
temperate climates. We report a case of a 15-year-old female patient, who was hospitalised due to right upper limb paresis
accompanied by a noticeable decline in both muscle strength and exteroceptive sensation. Extensive laboratory and imaging
assessments were conducted to rule out injury complications, as well as vascular and neurological disorders of the
head and cervical spine. Despite the absence of a history of tick bite or erythema migrans, Borrelia-specific IgM and IgG
antibodies were detected in the patient’s blood serum. Although initial cerebrospinal fluid analysis showed no antibodies,
subsequent testing confirmed the presence of Borrelia antibodies, confirming the neuroborreliosis. The patient received
a combination of antibiotic therapy, steroid therapy, and physiotherapy due to her clinical condition. Electroneurography
revealed nerve damage in the weakened upper limb. Given the escalating incidence of borreliosis cases, particularly in
paediatric populations, this case underscores the importance of heightened vigilance among specialists for such atypical
presentations like radiculopathy, emphasising the need for timely diagnosis and intervention.
Keywords: Lyme diseaseneuroborreliosisupper limb paresisradiculopathy
References
- Chomel B. Lyme disease. Rev Sci Tech. 2015; 34(2): 569–576.
- Stańczak J, Kubica-Biernat B, Racewicz M, et al. Detection of three genospecies of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected in different regions of Poland. Int J Med Microbiol. 2000; 290(6): 559–566.
- Brzozowska M, Wierzba A, Śliwczyński A, et al. The problem of Lyme borreliosis infections in urban and rural residents in Poland, based on National Health Fund data. Ann Agric Environ Med. 2021; 28(2): 277–282.
- Czarkowski M.P., Cielebąk E., Staszewska-Jakubik E., Barbara Kondej B. Infectious diseases and poisonings in Poland in 2017. https://wwwold.pzh.gov.pl/oldpage/epimeld/2017/Ch_2017.pdf (4.04.2024).
- Zachorowania na wybrane choroby zakaźne w Polsce od 1 stycznia do 31 grudnia 2023 r. oraz w porównywalnym okresie 2022 r. https://wwwold.pzh.gov.pl/oldpage/epimeld/2023/INF_23_12B.pdf (4.04.2024).
- Krzyczmanik D, Sińczuk-Walczak H, Wittczak T, et al. Borelioza w praktyce lekarza medycyny pracy. Med Pr. 2012; 63(4): 483–492.
- Kmieciak W, Ciszewski M, Szewczyk EM. [Tick-borne diseases in Poland: Prevalence and difficulties in diagnostics]. Med Pr. 2016; 67(1): 73–87.
- Smoleńska Ż, Matyjasek A, Zdrojewski Z. Borreliosis — the latest recommendations on diagnosis and treatment. Forum Reumatol. 2016; 2(2): 58–64.
- Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995; 333(20): 1319–1327.
- Stanek G, Wormser GP, Gray J, et al. Lyme borreliosis. Lancet. 2012; 379(9814): 461–473.
- Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin North Am. 2008; 22(2): 235–60, vi.
- Reiber H, Ressel C, Spreer A. Diagnosis of neuroborreliosis — improved knowledge base for qualified antibody analysis and cerebrospinal fluid data pattern related interpretations. Neurol Psychiatry Brain Res. 2013; 19(4): 159–169.
- Branda JA, Steere AC, Branda JA, et al. Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe. Clin Infect Dis. 2013; 57(3): 333–340.
- Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995; 333(20): 1319–1327.
- Södermark L, Sigurdsson V, Näs W, et al. Neuroborreliosis in Swedish children: a population-based study on incidence and clinical characteristics. Pediatr Infect Dis J. 2017; 36(11): 1052–1056.
- Mygland A, Ljøstad U, Fingerle V, et al. European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010; 17(1): 8–16, e1.
- Vukelic D, Bozinovic D, Morovic M, et al. Opsoclonus-myoclonus syndrome in a child with neuroborreliosis. J Infect. 2000; 40(2): 189–191.
- Ylitalo V, Hagberg BA. Progressive ataxia in Swedish children: a re-evaluation study. Acta Neurol Scand. 1994; 89(4): 299–302.
- Rupprecht TA, Koedel U, Fingerle V, et al. The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med. 2008; 14(3-4): 205–212.
- Radolf JD, Strle K, Lemieux JE, et al. Lyme disease in humans. Curr Issues Mol Biol. 2021; 42: 333–384.
- Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of lyme disease. Clin Infect Dis. 2021; 72(1): e1–e48.
- Ogrinc K, Lusa L, Lotrič-Furlan S, et al. Course and outcome of early european Lyme neuroborreliosis (Bannwarth syndrome): clinical and laboratory findings. Clin Infect Dis. 2016; 63(3): 346–353.
- Halperin JJ, Eikeland R, Branda JA, et al. North American Lyme neuroborreliosis. Scand J Infect Dis Suppl. 1991; 77(10): 74–80.
- Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985–1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain. 1992; 115 ( Pt 2): 399–423.
- Krawczuk K, Czupryna P, Pancewicz S, et al. Comparison of neuroborreliosis between children and adults. Pediatr Infect Dis J. 2020; 39(1): 7–11.
- Øymar K, Tveitnes D. Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe. Scand J Infect Dis. 2009; 41(2): 88–94.
- Monteiro SG, Arce SC, Vaca Ruiz G, et al. Bilateral diaphragmatic paralysis and Lyme neuroborreliosis. Ten years of follow-up. Medicina (B Aires). 2021; 81(3): 474–477.
- Marques A. Persistent symptoms after treatment of Lyme disease. Infect Dis Clin North Am. 2022; 36(3): 621–638.
- Sanchez E, Vannier E, Wormser GP, et al. Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA. 2016; 315(16): 1767–1777.
- Szer IS, Taylor E, Steere AC. The long-term course of Lyme arthritis in children. N Engl J Med. 1991; 325(3): 159–163.
- Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med. 1983; 99(1): 22–26.
- Dersch R, Freitag MH, Schmidt S, et al. Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review. Eur J Neurol. 2015; 22(9): 1249–1259.
- Kaiser R. [Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone]. Nervenarzt. 2004; 75(6): 553–557.
- Dersch R, Sommer H, Rauer S, et al. Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review. J Neurol. 2016; 263(1): 17–24.
- Dersch R, Hottenrott T, Schmidt S, et al. Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis in children: a systematic review. BMC Neurol. 2016; 16(1): 189.
- Rauer S, Kastenbauer S, Hofmann H, et al. Consensus group. Guidelines for diagnosis and treatment in neurology — Lyme neuroborreliosis. Ger Med Sci. 2020; 18: Doc03.
